Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GROWTH FRACTION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 244 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Michael-Robinson, JM; Reid, LE; Purdie, DM; Biemer-Huttmann, AE; Walsh, MD; Pandeya, N; Simms, LA; Young, JP; Leggett, BA; Jass, JR; Radford-Smith, GL
      Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer

      CLINICAL CANCER RESEARCH
    2. Valente, G; Pagano, M; Carrozzo, M; Carbone, M; Bobba, V; Palestro, G; Gandolfo, S
      Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    3. Menter, DG; Hoque, A; Motiwala, N; Sahin, AA; Sneige, N; Lieberman, R; Lippman, SM
      Computerized image analysis of Ki-67 in ductal breast carcinoma in situ

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    4. Wu, YL; Peng, CH; Shen, HW
      Expression of exon 13 from the Ki-67 gene in human cells and tissues by digoxigenin-labelled mRNA in situ hybridization

      CHINESE MEDICAL JOURNAL
    5. Adell, G; Zhang, H; Jansson, A; Sun, XF; Stal, O; Nordenskjold, B
      Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    6. Puglisi, F; Aprile, C; Bruckbauer, M; Barbone, F; Damante, G; Guerra, S; Beltrami, CA; Di Loreto, C
      Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas

      CANCER LETTERS
    7. Jacob, R; Welkoborsky, HJ; Mann, WJ; Jauch, M; Amedee, R
      [Fluorine-18]Fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck

      ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES
    8. Jacob, R; Welkoborsky, HJ; Bittinger, F; Mann, WJ; Amedee, R
      Histological grading, growth fraction and DNA-ploidy as criteria for the treatment of pharyngeal and supraglottic squamous cell carcinomas: A preliminary, prospective study

      ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES
    9. Higuchi, KH; Nakano, T; Tsuboi, A; Suzuki, Y; Ohno, T; Oka, K
      Flow cytometric and Ki-67 immunohistochemical analysis of cell cycle distribution of cervical cancer during radiation therapy

      ANTICANCER RESEARCH
    10. Schwartz, TH; Rhiew, R; Isaacson, SR; Orazi, A; Bruce, JN
      Association between intracranial plasmacytoma and multiple myeloma: Clinicopathological outcome study

      NEUROSURGERY
    11. Jacquet, B; Canet, V; Giroud, F; Montmasson, MP; Brugal, G
      Quantitation of AgNORs by flow versus image cytometry

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    12. Choma, D; Daures, JP; Quantin, X; Pujol, JL
      Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis ofpublished data

      BRITISH JOURNAL OF CANCER
    13. Barzanti, F; Dal Susino, M; Volpi, A; Amadori, D; Riccobon, A; Scarpi, E; Medri, L; Bernardi, L; Naldi, S; Aldi, M; Gaudio, M; Zoli, W
      Comparison between different cell kinetic variables in human breast cancer

      CELL PROLIFERATION
    14. Sviatoha, V; Tani, E; Rassidakis, G; Tribukait, B; Kleina, R; Skoog, L
      Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 proteinexpression in fine-needle aspirates from non-Hodgkin's lymphomas

      CYTOPATHOLOGY
    15. Indinnimeo, M; Cicchini, C; Stazi, A; Limiti, MR; Ghini, C; Mingazzini, P; Vecchione, A
      Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    16. Mettler, L; Volckers, S; Bidzinski, M
      Nuclear grading of endometrial cancer harbors heterogenous prognostic groups as detected by proliferation activity

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    17. Sakata, K; Oouchi, A; Nagakura, H; Akiba, H; Tamakawa, M; Koito, K; Hareyama, M; Asakura, K; Satoh, M; Ohtani, S
      Accelerated radiotherapy for T1, 2 glottic carcinoma: Analysis of results with Ki-67 index

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    18. Goodson WH, III; Moore, DH; Ljung, BM; Chew, K; Mayall, B; Smith, HS; Waldman, FM
      The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67

      BREAST CANCER RESEARCH AND TREATMENT
    19. Zhang, XH; Takenaka, I
      Cell proliferation and apoptosis with bcl-2 expression in renal cell carcinoma

      UROLOGY
    20. Ikeguchi, M; Oka, S; Gomyo, Y; Tsujitani, S; Maeta, M; Kaibara, N
      Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma

      JOURNAL OF SURGICAL ONCOLOGY
    21. Scholzen, T; Gerdes, J
      The Ki-67 protein: From the known and the unknown

      JOURNAL OF CELLULAR PHYSIOLOGY
    22. Endl, E; Gerdes, J
      Posttranslational modifications of the Ki-67 protein coincide with two major checkpoints during mitosis

      JOURNAL OF CELLULAR PHYSIOLOGY
    23. Oka, K; Suzuki, Y; Nakano, T
      High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma

      CANCER
    24. Kupryjanczyk, J; Dansonka-Mieszkowska, A; Szymanska, T; Karpinska, G; Rembiszewska, A; Rusin, M; Konopinski, R; Kraszewska, E; Timorek, A; Yandell, DW; Stelmachow, J
      Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction

      BRITISH JOURNAL OF CANCER
    25. Taniguchi, E; Yang, QF; Tang, WH; Nakamura, Y; Shan, L; Nakamura, M; Sato, M; Mori, I; Sakurai, T; Kakudo, K
      Cytologic grading of invasive breast carcinoma - Correlation with clinicopathologic variables and predictive value of nodal metastasis

      ACTA CYTOLOGICA
    26. Symmans, WF; Cangiarella, JF; Symmans, PJ; Cohen, JM; Yee, HT; Bennett, G; Amorosi, EL; Waisman, J
      Apoptotic index from fine needle aspiration cytology as a criterion to predict histologic grade of non-Hodgkin's lymphoma

      ACTA CYTOLOGICA
    27. Sasaki, M; Ishida, T; Horiuchi, H; Machinami, R
      Dermatofibrosarcoma protuberans: An analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression

      PATHOLOGY INTERNATIONAL
    28. Lavezzi, AM; Santambrogio, L; Bellaviti, N; Biondo, B; Nosotti, M; Radice, F; Matturri, L
      Prognostic significance of different biomarkers in non-small cell lung cancer

      ONCOLOGY REPORTS
    29. Steck, K; Hunt, K; Tucker, S; Singletary, S; El-Naggar, AK
      Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: Correlation with tumor and patient characteristics

      ONCOLOGY REPORTS
    30. Valente, G; Giusti, U; Kerim, S; Gabriele, P; Motta, M; Ragona, R; Navone, R; Palestro, G
      High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma

      ONCOLOGY REPORTS
    31. Schmitt, F; Tani, E; Tribukait, B; Skoog, L
      Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas

      CYTOPATHOLOGY
    32. Gorisse, MC; Venteo, L; Pluot, M
      A method for simultaneous quantification of monoclonal antibody Ki-67 and DNA content by flow cytometry - Application to breast carcinomas

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    33. Bonatz, G; Luttes, J; Hamann, S; Mettler, L; Jonat, W; Parwaresch, R
      Immunohistochemical assessment of p170 provides prognostic information in endometrial carcinoma

      HISTOPATHOLOGY
    34. Khoo, VS; Pollack, A; Cowen, D; Joon, DL; Patel, N; Terry, NHA; Zagars, GK; von Eschenbach, AC; Meistrich, ML; Troncoso, P
      Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy

      PROSTATE
    35. Tomaszewska, R; Karcz, D; Stachura, J
      An immunohistochemical study of the expression of bcl-2 and p53 oncoproteins in pancreatic intraepithelial neoplasia and pancreatic cancer

      INTERNATIONAL JOURNAL OF PANCREATOLOGY
    36. Tsang, RW; Wong, CS; Fyles, AW; Levin, W; Manchul, LA; Milosevic, M; Chapman, W; Li, YQ; Pintilie, M
      Tumour proliferation and apoptosis in human uterine cervix carcinoma II: Correlations with clinical outcome

      RADIOTHERAPY AND ONCOLOGY
    37. Rudolph, P; MacGrogan, G; Bonichon, F; Frahm, SO; de Mascarel, I; Trojani, M; Durand, M; Avril, A; Coindre, JM; Parwaresch, R
      Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast - A multivariate analysis of 863 cases

      BREAST CANCER RESEARCH AND TREATMENT
    38. Bonatz, G; Luttges, J; Hedderich, J; Jonat, W; Rudolph, P; Parwaresch, R
      Prognostic significance of a novel proliferation marker, anti-repp 86, forendometrial carcinoma: A multivariate study

      HUMAN PATHOLOGY
    39. Lehr, HA; Hansen, DA; Kussick, S; Li, M; Hwang, H; Krummenauer, F; Trouet, S; Gown, AM
      Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count

      HUMAN PATHOLOGY
    40. Frahm, SO; Rudolph, P; Dworeck, C; Zott, B; Heidebrecht, H; Steinmann, J; Neppert, J; Parwaresch, R
      Immunoenzymatic detection of the new proliferation associated protein p100by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M

      JOURNAL OF IMMUNOLOGICAL METHODS
    41. MacCallum, DE; Hall, PA
      Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding

      EXPERIMENTAL CELL RESEARCH
    42. Eissa, S; Labib, R; Khalifa, A; Swelam, N; Khalil, F; El-Shenawy, AM
      Regulators of apoptosis in human breast cancer

      CLINICAL BIOCHEMISTRY
    43. Brown, HM; Komorowski, RA; Wilson, SD; Demeure, MJ; Zhu, YR
      Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation - A positive correlation between MIB-1 staining and malignant tumor behavior

      CANCER
    44. Imamura, H; Haga, S; Shimizu, T; Watanabe, O; Kajiwara, T; Aiba, M
      Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma

      BRITISH JOURNAL OF CANCER
    45. Rudolph, P; Alm, P; Heidebrecht, HJ; Bolte, H; Ratjen, V; Baldetorp, B; Ferno, M; Olsson, H; Parwaresch, R
      Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    46. Andersen, SN; Rognum, TO; Bakka, A; Clausen, OPF
      Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    47. NAM JH; KIM JH; HUH J; KOH CW; NA JH; KIM BH; KIM YM; KIM YT; MOK JE
      CORRELATION OF LESION GRADE IN CERVICAL NEOPLASIA WITH CELL-PROLIFERATION AND APOPTOSIS

      International journal of gynecological cancer
    48. MASUDA M; SHINOKUMA A; HIRAKAWA N; NAKASHIMA T; KOMIYAMA S
      EXPRESSION OF BCL-2-, P53, AND KI-67 AND OUTCOME OF PATIENTS WITH PRIMARY NASOPHARYNGEAL CARCINOMAS FOLLOWING DNA-DAMAGING TREATMENT

      Head & neck
    49. KORKOLOPOULOU P; ANGELOPOULOU MK; KONTOPIDOU F; TSENGAS A; PATSOURIS E; KITTAS C; PANGALIS GA
      PROGNOSTIC IMPLICATIONS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA),AGNORS AND P53 IN NON-HODGKINS-LYMPHOMAS

      Leukemia & lymphoma
    50. HORIGUCHI J; IINO Y; TAKEI H; MAEMURA M; TAKEYOSHI I; YOKOE T; OHWADA S; OYAMA T; NAKAJIMA T; MORISHITA Y
      LONG-TERM PROGNOSTIC VALUE OF PCNA LABELING INDEX IN PRIMARY OPERABLEBREAST-CANCER

      Oncology Reports
    51. HEENEN M; THIRIAR S; NOEL JC; GALAND P
      KI-67 IMMUNOSTAINING OF NORMAL HUMAN EPIDERMIS - COMPARISON WITH H-3-THYMIDINE LABELING AND PCNA IMMUNOSTAINING

      Dermatology
    52. Bankfalvi, A; Schmitz, K; Mock, T; Kemper, M; Cubick, C; Bocker, W
      Relationship between AgNOR proteins, Ki-67 antigen, p53 immunophenotype and differentiation markers in archival breast carcinomas

      ANALYTICAL CELLULAR PATHOLOGY
    53. SCHIFTER M; JONES AM; WALKER DM
      EPITHELIAL P53 GENE-EXPRESSION AND MUTATIONAL ANALYSIS, COMBINED WITHGROWTH FRACTION ASSESSMENT, IN ORAL LICHEN-PLANUS

      Journal of oral pathology & medicine
    54. SANO K; YOSHIDA S; NINOMIYA H; IKEDA H; UENO K; SEKINE J; IWAMOTO H; UEHARA M; INOKUCHI T
      ASSESSMENT OF GROWTH-POTENTIAL BY MIB-1 IMMUNOHISTOCHEMISTRY IN AMELOBLASTIC FIBROMA AND RELATED LESIONS OF THE JAWS COMPARED WITH AMELOBLASTIC FIBROSARCOMA

      Journal of oral pathology & medicine
    55. PUJOL JL; DEMOLY P; QUANTIN X; SIMONY J; PARRAT E; LEHMANN M; DAURES JP; JOLIMOY G; GRENIER J; PAU B; GODARD P
      BIOLOGICAL PERSPECTIVES

      Revue des maladies respiratoires
    56. LIAO WM; CHIU KY; HAN SY; LI FB; QIU JS; CHOW SP
      PRELIMINARY OBSERVATION ON THE CORRELATION BETWEEN NM23 EXPRESSION AND KI-67 ANTIGEN WITH EARLY METASTASIS OF HUMAN OSTEOSARCOMA

      Chinese medical journal
    57. NAKANO T; OKA K; ISHIKAWA A; MORITA S
      IMMUNOHISTOCHEMICAL PREDICTION OF RADIATION RESPONSE AND LOCAL-CONTROL IN RADIATION-THERAPY FOR CERVICAL-CANCER

      Cancer detection and prevention
    58. Murata, O; Sakurai, H; Mitsuhashi, N; Hasegawa, M; Yamakawa, M; Kurosaki, H; Hayakawa, K; Niibe, H
      P-31 NMR spectroscopy can predict the optimum interval between fractionated irradiation doses

      ANTICANCER RESEARCH
    59. GORDOWER L; DECAESTECKER C; LOPES MB; CAMBY I; NAGY N; FRANCOIS C; CRAS P; MARTIN JJ; BROTCHI J; KISS R; SALMON I
      DETERMINATION OF GROWTH FRACTION AND CELL-DENSITY TO EVALUATE THE POTENTIAL GROWTH OF HUMAN OLIGODENDROGLIAL AND ASTROCYTIC TUMORS

      Journal of cancer research and clinical oncology
    60. GOODSON WH; MOORE DH; LJUNG BM; CHEW K; FLORENDO C; MAYALL B; SMITH HS; WALDMAN FM
      THE FUNCTIONAL-RELATIONSHIP BETWEEN IN-VIVO BROMODEOXYURIDINE LABELING INDEX AND KI-67 PROLIFERATION INDEX IN HUMAN BREAST-CANCER

      Breast cancer research and treatment
    61. DIRVEN CMF; KOUDSTAAL J; MOOIJ JJA; MOLENAAR WM
      THE PROLIFERATIVE POTENTIAL OF THE PILOCYTIC ASTROCYTOMA - THE RELATION BETWEEN MIB-1 LABELING AND CLINICAL AND NEURO-RADIOLOGICAL FOLLOW-UP

      Journal of neuro-oncology
    62. LOSA M; FRANZIN A; MORTINI P; TERRENI MR; MANGILI F; GIOVANELLI M
      USEFULNESS OF MARKERS OF CELL-PROLIFERATION IN THE MANAGEMENT OF PITUITARY-ADENOMAS

      Clinical science
    63. RUDOLPH P; PETERS J; LORENZ D; SCHMIDT D; PARWARESCH R
      CORRELATION BETWEEN MITOTIC AND KI-67 LABELING INDEXES IN PARAFFIN-EMBEDDED CARCINOMA SPECIMENS

      Human pathology
    64. FRAHM SO; ZOTT B; DWORECK C; STEINMANN J; NEPPERT J; PARWARESCH R
      IMPROVED ELISA PROLIFERATION ASSAY (EPA) FOR THE DETECTION OF IN-VITRO CELL-PROLIFERATION BY A NEW KI-67-ANTIGEN DIRECTED MONOCLONAL-ANTIBODY (KI-S3)

      Journal of immunological methods
    65. HEIDENREICH A; SESTERHENN IA; MOSTOFI FK; MOUL JW
      PROGNOSTIC RISK-FACTORS THAT IDENTIFY PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS AT LOW-RISK AND HIGH-RISK FOR METASTASIS

      Cancer
    66. Mooy, CM
      Ploidy analysis in uveal melanoma

      BRITISH JOURNAL OF OPHTHALMOLOGY
    67. JANSEN RLH; HUPPERETS PSGJ; ARENDS JW; JOOSTENACHJANIE SR; VOLOVICS A; SCHOUTEN HC; HILLEN HFP
      MIB-1 LABELING INDEX IS AN INDEPENDENT PROGNOSTIC MARKER IN PRIMARY BREAST-CANCER

      British Journal of Cancer
    68. ALLAL AS; ALONSOPENTZKE L; REMADI S
      APPARENT LACK OF PROGNOSTIC VALUE OF MIB-1 INDEX IN ANAL CARCINOMAS TREATED BY RADIOTHERAPY

      British Journal of Cancer
    69. KAWANA H; TAMARU J; TANAKA T; HIRAI A; SAITO Y; KITAGAWA M; MIKATA A; HARIGAYA K; KURIYAMA T
      ROLE OF P27(KIP1) AND CYCLIN-DEPENDENT KINASE-2 IN THE PROLIFERATION OF NONSMALL CELL LUNG-CANCER

      The American journal of pathology
    70. BRABENCOVA E; TAZI A; LORENZATO M; BONAY M; KAMBOUCHNER M; EMILE JF; HANCE AJ; SOLER P
      LANGERHANS CELLS IN LANGERHANS CELL GRANULOMATOSIS ARE NOT ACTIVELY PROLIFERATING CELLS

      The American journal of pathology
    71. MONGKONSRITRAGOON W; LETENDRE L; QIAN JQ; LI CY
      NODULAR LESIONS OF MONOCYTIC COMPONENT IN MYELODYSPLASTIC SYNDROME

      AJCP. American journal of clinical pathology
    72. VANOIJEN MGCT; MEDEMA RH; SLOOTWEG PJ; RIJKSEN G
      POSITIVITY OF THE PROLIFERATION MARKER KI-67 IN NONCYCLING CELLS

      AJCP. American journal of clinical pathology
    73. PERRET AG; MOSNIER JF; BUONO JP; BERTHELOT P; CHIPPONI J; BALIQUE JG; CUILLERET J; DECHELOTTE P; BOUCHERON S
      THE RELATIONSHIP BETWEEN MIB-1 PROLIFERATION INDEX AND OUTCOME IN PANCREATIC NEUROENDOCRINE TUMORS

      AJCP. American journal of clinical pathology
    74. ARBER JM; RIGGS MW; ARBER DA
      CORRELATION AMONG MIB-1, PARAFFIN SECTION PROLIFERATION INDEX, AND RECURRENCE IN LOW-STAGE BREAST-CARCINOMA

      Applied immunohistochemistry
    75. HEENEN M; GALAND P
      THE GROWTH FRACTION OF NORMAL HUMAN EPIDERMIS

      Dermatology
    76. BENINI E; RAO S; DAIDONE MG; PILOTTI S; SILVESTRINI R
      IMMUNOREACTIVITY TO MIB-1 IN BREAST-CANCER - METHODOLOGICAL ASSESSMENT AND COMPARISON WITH OTHER PROLIFERATION, INDEXES

      Cell proliferation
    77. PIERARD GE; PIERARDFRANCHIMONT C
      STOCHASTIC RELATIONSHIP BETWEEN THE GROWTH FRACTION AND VASCULARITY OF THIN MALIGNANT MELANOMAS

      European journal of cancer
    78. RUDAS M; NEUMAYER R; GNANT MFX; MITTELBOCK M; JAKESZ R; REINER A
      P53 PROTEIN EXPRESSION, CELL-PROLIFERATION AND STEROID-HORMONE RECEPTORS IN DUCTAL AND LOBULAR IN-SITU CARCINOMAS OF THE BREAST

      European journal of cancer
    79. OHASHI K; NEMOTO T; EISHI Y; MATSUNO A; NAKAMURA K; HIROKAWA K
      PROLIFERATIVE ACTIVITY AND P53 PROTEIN ACCUMULATION CORRELATE WITH EARLY INVASIVE TREND, AND APOPTOSIS CORRELATES WITH DIFFERENTIATION GRADE IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMAS

      Virchows Archiv
    80. IMAMURA H; HAGA S; SHIMIZU T; WATANABE O; KAJIWARA T; AIBA M
      MIB1-DETERMINED PROLIFERATIVE ACTIVITY IN INTRADUCTAL COMPONENTS AND PROGNOSIS OF INVASIVE DUCTAL BREAST-CARCINOMA

      Japanese journal of cancer research
    81. BENNO P; ALAM M; MIDTVEDT T; URIBE A
      SULFASALAZINE, OLSALAZINE AND SULFAPYRIDINE INDUCE MITOGENIC ACTIONS IN THE RAT INTESTINAL EPITHELIUM

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    82. PALESTRO G; PONTI R; CHIUSA L; CHIARLE R; GEUNA M; NOVERO D; FREILONE R; PICH A
      CELL-PROLIFERATION, BCL-2, C-MYC, P53 AND APOPTOSIS AS INDICATORS OF DIFFERENT AGGRESSIVENESS IN SMALL LYMPHOCYTIC LYMPHOMA (SLL)

      European journal of haematology
    83. KODAMA T; KAWAMOTO K; KONO T; SHIBUYA Y; SETOGAWA T
      COMPARISON OF IMMUNOSTAININGS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND KI-67 IN HUMAN EXTRAOCULAR LESIONS

      Graefe's archive for clinical and experimental ophthalmology
    84. DI X; NISHIZAKI T; HARADA K; KAJIWARA K; NAKAYAMA H; ITO H
      PROLIFERATIVE POTENTIALS OF GLIOMA-CELLS AND VASCULAR COMPONENTS DETERMINED WITH MONOCLONAL-ANTIBODY MIB-1

      Journal of experimental & clinical cancer research
    85. ABELE MC; VALENTE G; KERIM S; NAVONE R; ONESTI P; CHIUSA L; RESEGOTTI L; PALESTRO G
      SIGNIFICANCE OF CELL-PROLIFERATION INDEX IN ASSESSING HISTOLOGICAL PROGNOSTIC CATEGORIES IN HODGKINS-DISEASE - AN IMMUNOHISTOCHEMICAL STUDYWITH KI67 AND MIB-1 MONOCLONAL-ANTIBODIES

      Haematologica
    86. OKA K; NAKANO T; HOSHI T
      RELATIVE CHANGES OF MIB1 AND PC10 LABELING INDEXES IN CELL-KINETICS DURING RADIOTHERAPY FOR CERVICAL SQUAMOUS-CELL CARCINOMA

      Acta oncologica
    87. GERLACH C; SAKKAB DY; SCHOLZEN T; DASSLER R; ALISON MR; GERDES J
      KI-67 EXPRESSION DURING RAT-LIVER REGENERATION AFTER PARTIAL-HEPATECTOMY

      Hepatology
    88. KUWASHIMA Y; KOBAYASHI Y; KUROSUMI M; TANUMA J; SHIROMIZU K; KISHI K
      INVERSE CORRELATION BETWEEN BCL-2 EXPRESSION AND CELL-GROWTH FRACTIONIN HUMAN ENDOMETRIAL ADENOCARCINOMA TISSUE

      Anticancer research
    89. LEIVONEN M; NORDLING S; HAGLUND C
      DOES HELICOBACTER-PYLORI IN THE GASTRIC STUMP INCREASE THE CANCER RISK AFTER CERTAIN RECONSTRUCTION TYPES

      Anticancer research
    90. VICTORZON M; ROBERTS PJ; HAGLUND C; VONBOGUSLAWSKY K; NORDLING S
      KI-67, PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC FACTORS IN GASTRIC-CANCER

      Anticancer research
    91. GUINEBRETIERE JM; SABOURIN JC
      KI-67, A MARKER OF PROLIFERATION

      Annales de pathologie
    92. ASTSATUROV IA; SAMOILOVA RS; YAKHNINA EI; PIVNIK AV
      INVESTIGATION OF TUMOR CYTOLOGY AND GROWT H FRACTION IN CHRONIC LYMPHOPROLIFERATIVE DISEASES

      Gematologia i transfuziologia
    93. ISHIKURO A; DOSAKAAKITA H; KATO M; FUJINO M; ISOBE H; MIYAMOTO H; INOUE K; KAWAKAMI Y
      KI-67 LABELING INDEXES IN NONSMALL CELL LUNG-CANCER - COMPARISON BETWEEN IMAGE CYTOMETRY AND FLOW-CYTOMETRY

      Cytometry
    94. DONG HY; BERTLER C; SCHNEIDER E; RITTER MA
      ASSESSMENT OF CELL-PROLIFERATION BY AGNOR SCORES AND KI-67 LABELING INDEXES AND A COMPARISON WITH POTENTIAL DOUBLING TIMES

      Cytometry
    95. LEERS MPG; THEUNISSEN PHMH; RAMAEKERS FCS; SCHUTTE B
      MULTIPARAMETER FLOW CYTOMETRIC ANALYSIS WITH DETECTION OF THE KI67-AGIN PARAFFIN-EMBEDDED MAMMARY CARCINOMAS

      Cytometry
    96. COONS SW; JOHNSON PC; PEARL DK
      THE PROGNOSTIC-SIGNIFICANCE OF KI-67 LABELING INDEXES FOR OLIGODENDROGLIOMAS

      Neurosurgery
    97. DUNTON CJ; VANHOEVEN KH; KOVATICH AJ; OLIVER RE; SCACHERI RQ; CATER JR; CARLSON JA
      KI-67 ANTIGEN STAINING AS AN ADJUNCT TO IDENTIFYING CERVICAL INTRAEPITHELIAL NEOPLASIA

      Gynecologic oncology
    98. YONEZAWA K; TAMAKI N; KOKUNAI T
      CLINICAL-FEATURES AND GROWTH FRACTIONS OF PITUITARY-ADENOMAS

      Surgical neurology
    99. HEIDENREICH A; SCHENKMANN NS; SESTERHENN IA; MOSTOFI FK; MCCARTHY WF; HEIDENREICH B; MOUL JW
      IMMUNOHISTOCHEMICAL EXPRESSION OF KI-67 TO PREDICT LYMPH-NODE INVOLVEMENT IN CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS

      The Journal of urology
    100. STATTIN P; DAMBER JE; KARLBERG L; BERGH A
      CELL-PROLIFERATION ASSESSED BY KI-67 IMMUNOREACTIVITY ON FORMALIN-FIXED TISSUES IS A PREDICTIVE FACTOR FOR SURVIVAL IN PROSTATE-CANCER

      The Journal of urology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 19:11:08